Site Preservation After Tooth Extraction

Status Not yet recruiting

Clinical Trial Summary

This study is mainly targeted affected teeth which could not be retained, and patients are willing to undergo implant repair at the later stage. After teeth extraction, Geistlich Bio-Oss ® Particles or Bio-Oss ® Collagen are immediately implanted in the teeth extraction socket and covered with Bio-Gide ® collagen membrane for site preservation.Through postoperative follow-up, postoperative clinical and imaging objective indicators, combined with the subjective evaluation of surgeons and patients, and compared with conventional extraction treatment method, the study is aimed to evaluate the effectiveness of different site preservation of alveolar crest preservation, in order to reduce the alveolar bone width and height loss, effectively reduce alveolar bone absorption, or even achieve bone incrementation, thus to get the ideal site preservation effect, to improve the oral implant success rate, improve implant aesthetic score and patient satisfaction, provide more clinical standard reference of the clinical application of site preservation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05258019
Study type	Observational
Source	Nanfang Hospital of Southern Medical University
Contact	Qi Liu, Ph.D.
Phone	+86 20 62787153
Email	liuqi0721@smu.edu.cn
Status	Not yet recruiting
Phase
Start date	November 1, 2023
Completion date	October 31, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03557567` - NGS Strategy Effectiveness in Molecular Diagnosis
Not yet recruiting	`NCT05559801` - Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)	Phase 1/Phase 2
Active, not recruiting	`NCT02531087` - Urinary Biomarkers of OI Pathobiology
Completed	`NCT01713231` - Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta	Phase 4
Completed	`NCT00655681` - Prevention of Post Operative Bone Loss in Children	N/A
Recruiting	`NCT06065111` - Study of Osteogenesis Imperfecta Tendon
Withdrawn	`NCT03216486` - An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta	Phase 2
Recruiting	`NCT06086613` - A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers	Phase 1
Completed	`NCT04009733` - Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study	N/A
Completed	`NCT04231916` - High Resolution Thermal Imaging to Identify Vertebral Fractures in Children and Young People With Osteogenesis Imperfecta	N/A
Active, not recruiting	`NCT02814591` - Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy
Completed	`NCT00982124` - An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta	Phase 3
Completed	`NCT00001305` - Growth Hormone Therapy in Osteogenesis Imperfecta	Phase 3
Completed	`NCT04119388` - Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta	N/A
Terminated	`NCT01679080` - The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta	Phase 2
Completed	`NCT00106028` - Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children	Phase 3
Recruiting	`NCT04152551` - Effects of Bisphosphonates on OI-Related Hearing Loss	Phase 4
Completed	`NCT00705120` - Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation	Phase 1
Recruiting	`NCT04169568` - Osteogenesis Imperfecta Blood Pressure Study
Completed	`NCT03064074` - Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta	Phase 1